English French Notes Complete/Exclude ] New order(s) placed. ] New DC order(s) placed. Abnormal labs - [ Abnormal lab: Order requires electronic signature. ] Order placed: ] Result available: Procedure uses non-barium contrast media - abnormal biochem result: Recent Cholecystogram: Patient >65. Renal Results: Missing Labs for Angiogram: Patient allergic to contrast medias: Recent Barium study: WBC < 3.0 and/or ANC < 1.5 - pharmacy cannot fill clozapine order. Most recent results - Clozapine orders require a CBC/Diff within past 7 days. Please order CBC/Diff with WBC and ANC immediately. Most recent results - Most recent results - WBC between 3.0 and 3.5 with ANC >= 1.5 - please repeat CBC/Diff including WBC and ANC immediately and twice weekly. Most recent results - Clozapine - most recent results - Aminoglycoside - est. CrCl: Patient may be Est. CrCl: ordered - adjust diet accordingly. Procedure uses non-barium contrast media and patient is taking glucophage. Potential polypharmacy - patient currently receiving Labs resulted - [ Glucophage - Creatinine results: Glucophage - no serum creatinine within past ] Lab threshold exceeded - [ Patient has no allergy assessment. Duplicate opioid medications: When the transport routine encounters locally altered rule data at a site, do you want to: (O)verwrite, (D)isplay, or (A)sk the site ? Locally altered data will be overwritten without asking. Locally altered data will be displayed only. Sites will be asked before locally altered data is overwritten. Enter Patch ID (ex. OR*3*96): OR* v = Package Version. ppp = Patch Number. (Delete after Install of Scanning for old rule transport routines... No old rule transport routines found... These routines will be deleted and overwritten. Do you want to proceed? Old rule transport routines not deleted (^%ZOSF( Not Deleted... Select an ***** Already selected for transport. ***** None Selected for transport Already selected for transport: Press to continue... added to list. removed from list. Select a selected for transport. ORDER CHECK OCX MDD unknown lookup error. could not resolve name. End Transport. already existed. record missing... Unresolved subscript. ^DIE filer data error... ...Correct data Filed Rule Transport aborted, version mismatch. Rule Transport Version: |CVER| Order Check Expert System Rule Transporter data filing error Some expert system rules may be incomplete. No data filing errors. Transport Finished... ] ERROR - RECORD NOT FOUND ACD EXTRACT V10.1 Available record layouts: 1) VAACCR Record Layout Version 10.1 (VA Registry) 2) NAACCR State Record Layout Version 10.1 Select record layout: Select the record layout to use VACCR EXTRACT V10.1 STATE EXTRACT V10.1 DISPLAY/PRINT on-line instructions STATE REPORTING ACOS INFOA PRIMARY ACOS INFO (850) Select start date: Select end date: Analytic cases only Answer 'YES' if you want only analytic cases (CLASS OF CASE 0-2) extracted. Answer 'NO' if you want all cases (analytic and non-analytic) extracted. |Please activate your PC capture program. The data will be sent| | in 30 seconds or when you press the return key. | No records extracted. ACoS Report Print State Extract Print Report Canceled! Report Queued! These are your current settings: Record layout.......................: Facility Identification Number (FIN): State to be extracted...............: Accession Year......................: Start date..........................: End date............................: Analytic cases only.................: Are these settings correct Accession Year: Facility Identification Number (FIN) The site paramaters record is being edited by another user. Press ENTER to Continue or to Quit: Col# Data item Data Value ONC( ICDO-TOPOGRAPHY is not defined .........: Surgery performed .........: Radiation performed The Accession Year is not 1995. The Diagnostic Confirmation code is not 1. The Class of Case code is not 0, 1 or 2. Date DX and/or First Treatment Date not in 1995. Select table This primary does not satisfy the PCE eligibility criteria: Patient Care Evaluation Study of Cancers of the Urinary Bladder ACCESSION/SEQUENCE NUMBER CLASS OF CASE REFERRED FOR TREATMENT TO ZIP AT DIAGNOSIS SPANISH ORIGIN PRIMARY PAYER AT DIAGNOSIS PATIENT HISTORY OF OTHER CANCER FAMILY HISTORY OF CANCER SMOKING HISTORY DURATION OF SMOKING HISTORY DURATION OF SMOKE-FREE HISTORY TABLE I - GENERAL INFORMATION ACCESSION/SEQUENCE NUMBER.....: CLASS OF CASE.................: 300REFERRED FOR TREATMENT TO..... 9ZIP AT DIAGNOSIS.............. DATE OF BIRTH.................: 9SPANISH ORIGIN................ 18PRIMARY PAYER AT DIAGNOSIS.... 301LENGTH OF STAY................ PATIENT HISTORY OF OTHER CANCER: 305 HEAD AND NECK............... FAMILY HISTORY OF CANCER: 314SMOKING HISTORY (PACKS/DAY)... 315DURATION OF SMOKING HISTORY... 316DURATION OF SMOKE-FREE HISTORY GO TO: CLINICAL DETECTION ONSET OF SYMPTOMS DURATION OF SYMPTOMS BEFORE DIAGNOSIS DIAGNOSTIC PROCEDURES DATE OF INITIAL DIAGNOSIS SPECIALTY MAKING DIAGNOSIS PRIMARY SITE (ICD-O-2) HISTOLOGY (ICD-O-2) TABLE II- DIAGNOSTIC INFORMATION CLINICAL DETECTION: 317 GROSS HEMATURIA................ 318 MICROSCOPIC HEMATURIA.......... 319 URINARY FREQUENCY.............. 320 BLADDER IRRITABILITY........... 323ONSET OF SYMPTOMS................ DURATION OF SYMPTOMS (months) BEFORE DIAGNOSIS: 324 GROSS HEMATURIA................ DIAGNOSTIC PROCEDURES: 326 BIMANUAL EXAMINATION OF BLADDER 327 CYSTOSCOPY WITH BIOPSY......... 328 CYSTOSCOPY WITHOUT BIOPSY...... 329 FLOW CYTOMETRY................. 330 INTRAVENOUS PYELOGRAM.......... 331 URINE CYTOLOGY................. DATE OF INITIAL DIAGNOSIS........: 334SPECIALTY MAKING DIAGNOSIS....... PRIMARY SITE (ICD-O-2)...........: HISTOLOGY (ICD-O-2)..............: STAGING PROCEDURES PRESENCE OF HYDRONEPHROSIS TUMOR SIZE (mm) PRESENCE OF MULTIPLE TUMORS REGIONAL NODES EXAMINED REGIONAL NODES POSITIVE SITES OF DISTANT METASTASIS AJCC CLINICAL STAGE (cTNM) AJCC PATHOLOGIC STAGE (pTNM) STAGED BY TABLE III- EXTENT OF DISEASE AND AJCC STAGE STAGING PROCEDURES: 335 ABDOMINAL ULTRASOUND......... 336 BONE IMAGING................. 338 CT CHEST/LUNG................ 339 CT ABDOMEN/PELVIS............ 340 CT OTHER..................... 341 MRI PELVIS/ABDOMEN........... 342 MRI OTHER.................... 344PRESENCE OF HYDRONEPHROSIS..... 29TUMOR SIZE (mm)................ 345PRESENCE OF MULTIPLE TUMORS.... 33REGIONAL NODES EXAMINED........ 32REGIONAL NODES POSITIVE........ SITES OF DISTANT METASTASIS: 34 SITE OF DISTANT METASTASIS #1 SITE OF DISTANT METASTASIS #2: None SITE OF DISTANT METASTASIS #3: None 34.1 SITE OF DISTANT METASTASIS #2 34.2 SITE OF DISTANT METASTASIS #3 AJCC CLINICAL STAGE (cTNM): 38AJCC STAGE..................... AJCC PATHOLOGIC STAGE (pTNM): 88AJCC STAGE..................... STAGED BY: 19 CLINICAL STAGE.................... 89 PATHOLOGIC STAGE.................. DATE OF INITIAL TREATMENT PROTOCOL ELIGIBILITY STATUS MANAGING PHYSICIANS RADIATION THERAPY TABLE IV - FIRST COURSE OF TREATMENT DATE OF INITIAL TREATMENT...........: 346PROTOCOL ELIGIBILITY STATUS......... MANAGING PHYSICIANS: 347 PRIMARY PHYSICIAN................. 348 SECONDARY PHYSICIAN............... SURGERY: DATE OF SURGERY...................: TYPE OF SURGERY...................: TUMOR RESECTION DURING TURB.......: Not applicable 349 TUMOR RESECTION DURING TURB....... TYPE OF URINARY DIVERSION.........: Not applicable 350 TYPE OF URINARY DIVERSION......... PELVIC LYMPH NODE DISSECTION......: Not applicable 351 PELVIC LYMPH NODE DISSECTION...... SURGICAL COMPLICATIONS: BLEEDING REQUIRING TRANSFUSION..: No DEEP VENOUS THROMBOSIS..........: No MYOCARDIAL INFARCTION/ARRHYTHMIA: No PELVIC ABSCESS..................: No PNEUMONIA REQUIRING ANTIBIOTICS.: No POST-OPERATIVE DEATH (30 DAYS)..: No PULMONARY EMBOLISM/THROMBOSIS...: No 352 BLEEDING REQUIRING TRANSFUSION.. 353 DEEP VENOUS THROMBOSIS.......... 354 MYOCARDIAL INFARCTION/ARRHYTHMIA 355 PELVIC ABSCESS.................. 356 PNEUMONIA REQUIRING ANTIBIOTICS. 357 POST-OPERATIVE DEATH (30 DAYS).. 358 PULMONARY EMBOLISM/THROMBOSIS... RADIATION THERAPY: RADIATION THERAPY.................: DATE RADIATION THERAPY STARTED....: DATE RADIATION THERAPY ENDED......: 00/00/0000 TOTAL RAD (cGy/rad) DOSE..........: 00000 REGIONAL TREATMENT MODALITY.......: No radiation therapy RADIATION COMPLICATIONS: URINARY INCONTINENCE............: Not applicable HEMATURIA.......................: Not applicable RADIATION BOWEL INJURY..........: Not applicable DATE RADIATION THERAPY ENDED......: 99/99/9999 TOTAL RAD (cGy/rad) DOSE..........: 99999 REGIONAL TREATMENT MODALITY.......: Unknown URINARY INCONTINENCE............: Unknown RADIATION BOWEL INJURY..........: Unknown 361 DATE RADIATION THERAPY ENDED...... 362 TOTAL RAD (cGy/rad) DOSE.......... 363 REGIONAL TREATMENT MODALITY....... 364 URINARY INCONTINENCE............ 366 RADIATION BOWEL INJURY.......... CHEMOTHERAPY: DATE CHEMOTHERAPY STARTED.........: DATE CHEMOTHERAPY ENDED...........: 00/00/0000 ROUTE CHEMOTHERAPY ADMINISTERED...: No chemotherapy TYPES OF AGENTS ADMINISTERED: ADRIAMYCIN......: None IFOSFAMIDE......: None CARBOPLATINUM...: None METHOTREXATE....: None CISPLATIN.......: None TAXOL...........: None CYCLOPHOSPHAMIDE: None THIOTEPA........: None 5-FLUOROURACIL..: None VINBLASTINE.....: None GALLIUM NITRATE.: None OTHER...........: None INDICATION FOR ADMIN OF AGENTS....: No agents administered, NA REASON CHEMOTHERAPY STOPPED.......: Treatment completed, NA DATE CHEMOTHERAPY ENDED...........: 99/99/9999 ROUTE CHEMOTHERAPY ADMINISTERED...: Unknown ADRIAMYCIN......: Unknown IFOSFAMIDE......: Unknown CARBOPLATINUM...: Unknown METHOTREXATE....: Unknown CISPLATIN.......: Unknown TAXOL...........: Unknown CYCLOPHOSPHAMIDE: Unknown THIOTEPA........: Unknown 5-FLUOROURACIL..: Unknown VINBLASTINE.....: Unknown GALLIUM NITRATE.: Unknown OTHER...........: Unknown INDICATION FOR ADMIN OF AGENTS....: Unknown REASON CHEMOTHERAPY STOPPED.......: Unknown 367 DATE CHEMOTHERAPY ENDED........... 368 ROUTE CHEMOTHERAPY ADMINISTERED... 374 GALLIUM NITRATE................. 380 OTHER AGENT..................... 381 INDICATION FOR ADMIN OF AGENTS.... 382 REASON CHEMOTHERAPY STOPPED....... IMMUNOTHERAPY: #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### ####################